Get the Stockscreener App
8.00
1.11%
-0.09
After Hours:
8.10
0.10
+1.25%
Cogent Biosciences Inc Stock (COGT) Forecast
The Cogent Biosciences Inc (COGT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.4604, representing a -44.25% decrease from the current price of $8.00. The highest analyst price target is $6.1755, and the lowest is $2.7452.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month COGT Price Target
Average 4.5015
(-43.73% Downside)
Is Cogent Biosciences Inc (COGT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.50 | Neutral |
| STOCH(9,6) | 9.3007 | Buy |
| STOCHRSI(14) | 5.1139 | Buy |
| MACD(12,26) | -0.1321 | Sell |
| ADX(14) | 12.35 | Neutral |
| William %R | -94.15 | Buy |
| CCI(14) | -60.96 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.254
Sell
|
8.2702
Sell
|
| MA20 |
8.6795
Sell
|
8.4169
Sell
|
| MA50 |
8.3488
Sell
|
8.634
Sell
|
| MA100 |
9.4559
Sell
|
8.9528
Sell
|
| MA200 |
9.2853
Sell
|
8.8085
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, COGT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on COGT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.5 indicates that COGT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 9.3007 indicates that COGT is oversold. This indicates that COGT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.1139 indicates that COGT is oversold. This suggests that COGT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.35 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -60.96 indicates that COGT is still oversold but not to an extreme extent.
Long-term COGT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cogent Biosciences Inc financial reports and earnings history, Cogent Biosciences Inc (COGT) stock could reach $3.2605 by 2030, $4.6384 by 2040 and $12.11 by 2050. See the projected annual prices until 2050 of the Cogent Biosciences Inc stock below:
- Cogent Biosciences Inc (COGT) is expected to reach an average price of $2.3608 in 2035, with a high prediction of $5.7301 and a low estimate of $1.9008. This indicates an $-70.49% rise from the last recorded price of $8.00.
- Cogent Biosciences Inc (COGT) stock is projected to chart a bullish course in 2040, with an average price target of $4.4879, representing an $-43.90% surge from its current level. The forecast ranges from a conservative $4.8193 to a sky-high $4.6384.
- Our analysts predict Cogent Biosciences Inc (COGT) to jump 18.55% by 2045, soaring from $10.59 to an average price of $9.4842, potentially reaching $10.62. While $10.59 is the low estimate, the potential upside is significant.
- Cogent Biosciences Inc (COGT) stock is expected to climb by 2050, reaching an average of $13.60, a $69.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.11 and $11.68, respectively, highlighting the market's uncertainty.
Cogent Biosciences Inc Stock (COGT) Year by Year Forecast
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2025
Cogent Biosciences Inc Stock (COGT) is expected to reach an average price of $5.1585 in 2025, with a high prediction of $8.0623 and a low estimate of $2.2547. This indicates an -35.52% fall from the last recorded price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $5.8855 | $2.7452 | $6.1755 | -26.43% |
| April, 2025 | $5.9411 | $4.7306 | $6.2806 | -25.74% |
| May, 2025 | $4.5316 | $4.4916 | $6.0262 | -43.36% |
| June, 2025 | $5.742 | $4.8567 | $6.4656 | -28.22% |
| July, 2025 | $5.2676 | $4.3676 | $8.0623 | -34.15% |
| August, 2025 | $5.6181 | $4.7028 | $5.9908 | -29.77% |
| September, 2025 | $3.7586 | $3.5591 | $5.9582 | -53.02% |
| October, 2025 | $3.0942 | $2.6642 | $4.8688 | -61.32% |
| November, 2025 | $3.9247 | $2.2547 | $3.9547 | -50.94% |
| December, 2025 | $5.8703 | $3.7598 | $6.1303 | -26.62% |
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2026
The predicted value for Cogent Biosciences Inc (COGT) in 2026 is set at an average of $8.1319. Estimates vary from a peak of $15.32 to a trough of $0.9407, indicating an +1.65% surge from the present price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2107 | $0.9407 | $5.9054 | -84.87% |
| February, 2026 | $1.5012 | $1.1159 | $2.5261 | -81.23% |
| March, 2026 | $6.2117 | $1.4863 | $8.0662 | -22.35% |
| April, 2026 | $8.3073 | $5.8168 | $9.2922 | +3.84% |
| May, 2026 | $13.49 | $7.3124 | $14.38 | +68.60% |
| June, 2026 | $13.04 | $12.38 | $15.32 | +62.98% |
| July, 2026 | $11.28 | $9.8407 | $13.43 | +41.05% |
| August, 2026 | $9.7243 | $8.6443 | $11.80 | +21.55% |
| September, 2026 | $8.4299 | $7.8894 | $10.32 | +5.37% |
| October, 2026 | $9.8504 | $7.8051 | $10.54 | +23.13% |
| November, 2026 | $12.43 | $8.9355 | $12.48 | +55.39% |
| December, 2026 | $10.63 | $9.8713 | $13.06 | +32.83% |
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cogent Biosciences Inc (COGT) is $6.1453, with a high forecast of $10.98 and a low forecast of $1.3071. This indicates an -23.18% decrease from the last price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.5269 | $7.0669 | $10.92 | -5.91% |
| February, 2027 | $8.6774 | $7.2423 | $8.9574 | +8.47% |
| March, 2027 | $8.693 | $7.7179 | $10.07 | +8.66% |
| April, 2027 | $9.6235 | $8.6731 | $10.98 | +20.29% |
| May, 2027 | $10.03 | $8.9037 | $10.27 | +25.42% |
| June, 2027 | $9.5296 | $7.8996 | $10.88 | +19.12% |
| July, 2027 | $10.53 | $8.7547 | $10.69 | +31.63% |
| August, 2027 | $7.3205 | $7.0505 | $10.79 | -8.49% |
| September, 2027 | $5.7561 | $5.7461 | $7.8356 | -28.05% |
| October, 2027 | $4.3066 | $4.0466 | $6.5712 | -46.17% |
| November, 2027 | $2.5171 | $1.3071 | $7.1819 | -68.54% |
| December, 2027 | $2.2527 | $2.0922 | $4.3624 | -71.84% |
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2028
In 2028, Cogent Biosciences Inc (COGT) is projected to reach an average price of $4.3191, with a high projection of $7.9534 and a low estimate of $0.6848. This indicates an -46.01% fall from the last price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.5631 | $1.9529 | $4.2996 | -55.46% |
| February, 2028 | $4.9336 | $3.0583 | $7.9534 | -38.33% |
| March, 2028 | $4.4392 | $3.4541 | $5.1487 | -44.51% |
| April, 2028 | $4.2497 | $3.6246 | $5.1446 | -46.88% |
| May, 2028 | $4.0807 | $2.5607 | $7.8302 | -48.99% |
| June, 2028 | $6.4517 | $1.8517 | $7.3517 | -19.35% |
| July, 2028 | $4.7226 | $3.3519 | $7.2921 | -40.97% |
| August, 2028 | $3.5338 | $2.0136 | $6.7531 | -55.83% |
| September, 2028 | $1.5148 | $0.6848 | $4.4341 | -81.07% |
| October, 2028 | $2.4057 | $1.385 | $3.1555 | -69.93% |
| November, 2028 | $2.3669 | $1.6564 | $2.926 | -70.41% |
| December, 2028 | $2.3779 | $1.3874 | $2.6872 | -70.28% |
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2029
The 2029 price forecast for Cogent Biosciences Inc Stock (COGT) is $2.5374 on average, with a high prediction of $5.0646 and a low estimate of $0.0102. This represents an -68.28% decrease from the previous price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.8791 | $1.4084 | $3.3386 | -76.51% |
| February, 2029 | $0.29 | $0.0102 | $2.0593 | -96.37% |
| March, 2029 | $2.811 | $0.2297 | $3.101 | -64.86% |
| April, 2029 | $2.3119 | $1.6612 | $3.2112 | -71.10% |
| May, 2029 | $1.5031 | $1.4631 | $2.9824 | -81.21% |
| June, 2029 | $2.7341 | $1.8334 | $3.4423 | -65.82% |
| July, 2029 | $1.945 | $1.745 | $5.0646 | -75.69% |
| August, 2029 | $2.6562 | $1.3853 | $3.0135 | -66.80% |
| September, 2029 | $0.8172 | $0.6177 | $3.0015 | -89.79% |
| October, 2029 | $0.1784 | $0.0481 | $1.9377 | -97.77% |
| November, 2029 | $1.0293 | $0.0188 | $1.0593 | -87.13% |
| December, 2029 | $3.0603 | $0.8696 | $3.2302 | -61.75% |
Cogent Biosciences Inc Stock (COGT) Price Forecast for 2030
Cogent Biosciences Inc Stock (COGT) is expected to reach an average price of $6.4436 in 2030, with a high forecast of $12.58 and a low forecast of $0.311. This signifies an -19.45% decrease from the last price of $8.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6385 | $0.311 | $3.2605 | -79.52% |
| February, 2030 | $1.3276 | $1.0778 | $0.9876 | -83.41% |
| March, 2030 | $3.4034 | $1.2599 | $5.2426 | -57.46% |
| April, 2030 | $5.3443 | $3.0136 | $6.5043 | -33.20% |
| May, 2030 | $10.73 | $4.5348 | $11.62 | +34.07% |
| June, 2030 | $10.30 | $9.6365 | $12.58 | +28.71% |
| July, 2030 | $8.5677 | $7.1194 | $10.70 | +7.10% |
| August, 2030 | $7.0286 | $5.9486 | $9.0982 | -12.14% |
| September, 2030 | $7.5596 | $5.1989 | $7.6496 | -5.51% |
| October, 2030 | $7.2008 | $5.1453 | $7.8701 | -9.99% |
| November, 2030 | $9.8017 | $6.291 | $9.8517 | +22.52% |
| December, 2030 | $7.3827 | $7.2627 | $10.43 | -7.72% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):